title: [The results of using lucetam in patients with moderate cognitive impairment of different genesis].
authors.forename: T T
authors.initials: TT
authors.lastname: Batysheva
authors.forename: O V
authors.initials: OV
authors.lastname: Otcheskaia
authors.forename: O N
authors.initials: ON
authors.lastname: Nesterova
authors.forename: L N
authors.initials: LN
authors.lastname: Lisinker
authors.forename: L A
authors.initials: LA
authors.lastname: Bobina
authors.forename: A M
authors.initials: AM
authors.lastname: Ismailov
authors.forename: R K
authors.initials: RK
authors.lastname: Shekkhirimov
authors.forename: E Iu
authors.initials: EIu
authors.lastname: Zhuravleva
authors.forename: P R
authors.initials: PR
authors.lastname: Kamchatnov
authors.forename: A N
authors.initials: AN
authors.lastname: Boĭko
mesh_terms: D000368:Aged; D001927:Brain Diseases / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D003071:Cognition / Q000187:drug effects / Q000502:physiology*; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D018697:Nootropic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D010889:Piracetam / Q000008:administration & dosage / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D018697:Nootropic Agents; D010889:Piracetam